ArticlePloS one2026
Therapeutic potential of flavonoids and rutin against inflammation-induced on a huntington animal model.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study tested the hypothesis that flavonoids (diosmine, hesperidin and rutin®) play a protective role in the brain and duodenum against 3-Nitropropionic acid (3-NPA) free radical induced inflammation. This was achieved by measuring the levels of GABA, 5-HIAA, dopamine and some inflammation and oxidative stress markers. Male young Wistar rats (weight 60g) received Salmonella thyphimurium ATCC14028 1x106 CFU/g every week, for two consecutive weeks, plus the following treatments: group A, 0.9% NaCl (Control); group B, diosmine (300 mg) + hesperidin (33.3g) + rutin (150 mg/kg); group C, 3-NPA; group D, 3-NPA + mix of flavonoids with 1 ml of rutin® per rat. 3-NPA administration was at 24 mg/kgW by intraperitoneal route and the flavonoids were orally administered at every 48 hours for 15 days. At the moment of euthanasia, the blood was obtained to assess Interleukine-6, glucose, triglycerides and hemoglobin levels. Brain and duodenum were obtained to measure GABA, dopamine, 5-HIAA, lipoperoxidation, reduced glutathione (GSH), total ATPase concentrations and catalase activity using validated methods. The brains, stomach and duodenum were dissected for histological analysis. In group A, there is a decrease in interleukine-6 levels (p = 0.009). In the cortex region of animals in group C, dopamine experienced a significant decrease (p = 0.012). GABA increased (p = 0.001) in cerebellum regions of animals in the groups A, B and C. ATPase activity increased (p = 0.013) in cerebellum regions in animals of groups C and D. Lipoperoxidation diminished (p = 0.043) in cerebellum region of group D. Catalase activity diminished (p = 0.043) in Cortex region of animals in groups B and D, and (p = 0.002) in cerebellum region of animals in groups A and B. Besides, histological changes revealed marked lesions of neuronal cells in experimental animals treated with nitro propionic acid. The protective role of flavonoids and rutin compounds on inhibition of the inflammatory response and correction of the fundamental oxidant/antioxidant imbalance in animals suffering from Huntington diseases are important vistas for further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.